WHO ICTRP trial
Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease (PERSEUS)
JPRN-UMIN000010453 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000010453 |
|---|---|
| Public title | Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease (PERSEUS) |
| Scientific title | Cardiac Progenitor Cell Infusion to Treat Univentricular Heart Disease (PERSEUS) - Cardiac Progenitor Cell Transfer for Univentricular Heart |
| Primary sponsor | Okayama University Hospital |
| Secondary sponsors | Translational Research Informatics Center |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Hypoplastic left heart syndrome Single right ventricle Single left ventricle |
| Interventions | (Stage 1) single dose, intracoronary infusion of 0.3 million cell/kg cardiac progenitor cells (cell infusion group). (Stage 2) Rescuing transplantation is applicable in patients, along with their written consent, 4 months after palliations… |
| Registration date | Oct 4, 2013 |
| Target size | 34 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: